EP2560658

ENHANCING ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    21.4.2011
  • EP published:
    22.2.2017
  • EP application number:
    11772735.4
  • Max expiry date:
    20.4.2031
  • Title:
    ENHANCING ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY

Timeline

Today
21.4.2011EP application
22.2.2017EP Publication

Owner

  • Name:
    VentiRx Pharmaceuticals, Inc.
  • Address:
    1191 Second Avenue, Suite 1105, 98101, Seattle, WA, US

Inventor

  • Name:
    HERSHBERG, Robert
  • Address:
    Seattle, WA, US

Priority

  • Number:
    326406 P
  • Date:
    21.4.2010
  • Country:
    US

Classification

  • Categories:
    A61K 31/55, A61K 39/395, A61P 35/02, A61P 35/00, A61K 45/06, C07K 16/28, C07K 16/32

Upload documents